Document Detail


Acne vaccines: therapeutic option for the treatment of acne vulgaris?
MedLine Citation:
PMID:  18787542     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Acne, one of the most common skin diseases, is caused by multiple factors, including Propionibacterium acnes. Studies suggest that responses to P. acnes by host immunity play important roles in its pathogenesis. Identifying immune modulators that attenuate inflammatory responses against P. acnes and the inhibition of bacterial growth may lead to novel avenues of immunologic intervention.
Authors:
Jenny Kim
Publication Detail:
Type:  Comment; Editorial    
Journal Detail:
Title:  The Journal of investigative dermatology     Volume:  128     ISSN:  1523-1747     ISO Abbreviation:  J. Invest. Dermatol.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-12     Completed Date:  2008-10-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0426720     Medline TA:  J Invest Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2353-4     Citation Subset:  IM    
Affiliation:
Division of Dermatology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. jekim@mednet.ucla.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / drug therapy*
Animals
Antibodies, Bacterial / therapeutic use
Bacterial Vaccines / therapeutic use*
Humans
Propionibacterium acnes / immunology*
Chemical
Reg. No./Substance:
0/Antibodies, Bacterial; 0/Bacterial Vaccines
Comments/Corrections
Comment On:
J Invest Dermatol. 2008 Oct;128(10):2451-7   [PMID:  18463682 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Seasonal palmar keratoderma in erythropoietic protoporphyria indicates autosomal recessive inheritan...
Next Document:  Germline MC1R variants and BRAF mutant melanoma.